Posted : 2020-12-31 20:16
Updated : 2020-12-31 21:44
Jung Eun-kyeong, commissioner of Korea Disease Control and Prevention Agency, speaks during a press briefing at KDCA on Thursday. / Yonhap
South Korea on Thursday signed a deal with U.S. biotech company Moderna to buy new coronavirus vaccine doses for 20 million people, with the supply to begin in the second quarter of next year, health authorities said.
Following the deal, the total amount of COVID-19 vaccines South Korea has secured is enough to inoculate 56 million people, more than enough to cover the country's population of 52 million, according to the Korea Disease Control and Prevention Agency (KDCA).